Search

everythinglearnresearchcommunity

for

Search:↓

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

Platelet-Rich Fibrin shows promise in medicine and dentistry, but more research is needed to standardize its use.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

L-PRF effectively improved healing and bone integration in dental implant surgery.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

Hair follicle sampling is a feasible method to measure FMRP and FMR1 mRNA levels in children.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

A protein called sFRP4 can slow down hair regrowth.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

FLRG and follistatin have different roles in wound healing.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.